CN113121681B - 一种抗炎抗猪流行性腹泻病毒卵黄抗体及其应用 - Google Patents
一种抗炎抗猪流行性腹泻病毒卵黄抗体及其应用 Download PDFInfo
- Publication number
- CN113121681B CN113121681B CN202110668820.8A CN202110668820A CN113121681B CN 113121681 B CN113121681 B CN 113121681B CN 202110668820 A CN202110668820 A CN 202110668820A CN 113121681 B CN113121681 B CN 113121681B
- Authority
- CN
- China
- Prior art keywords
- yolk antibody
- pedv
- porcine epidemic
- epidemic diarrhea
- egg yolk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002969 egg yolk Anatomy 0.000 title claims abstract description 85
- 102000002322 Egg Proteins Human genes 0.000 title claims abstract description 47
- 108010000912 Egg Proteins Proteins 0.000 title claims abstract description 47
- 235000013345 egg yolk Nutrition 0.000 title claims abstract description 44
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 title claims abstract description 38
- 230000003110 anti-inflammatory effect Effects 0.000 title claims abstract description 23
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims abstract description 38
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims abstract description 36
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims abstract description 33
- 206010012735 Diarrhoea Diseases 0.000 claims abstract description 31
- 241000700605 Viruses Species 0.000 claims abstract description 24
- 229960005486 vaccine Drugs 0.000 claims abstract description 13
- 102000007079 Peptide Fragments Human genes 0.000 claims abstract description 8
- 108010033276 Peptide Fragments Proteins 0.000 claims abstract description 8
- 238000010353 genetic engineering Methods 0.000 claims abstract description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 31
- 102000004169 proteins and genes Human genes 0.000 claims description 23
- 230000003053 immunization Effects 0.000 claims description 20
- 230000014509 gene expression Effects 0.000 claims description 12
- 101001028244 Onchocerca volvulus Fatty-acid and retinol-binding protein 1 Proteins 0.000 claims description 11
- 239000013612 plasmid Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 9
- 235000013601 eggs Nutrition 0.000 claims description 9
- 238000012408 PCR amplification Methods 0.000 claims description 8
- 108091007433 antigens Proteins 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 239000000427 antigen Substances 0.000 claims description 6
- 102000036639 antigens Human genes 0.000 claims description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 4
- 210000004185 liver Anatomy 0.000 claims description 3
- 239000003674 animal food additive Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 241000352457 Shivajiella indica Species 0.000 claims 3
- 230000001131 transforming effect Effects 0.000 claims 2
- 241000282898 Sus scrofa Species 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 9
- 230000002265 prevention Effects 0.000 abstract description 6
- 230000002757 inflammatory effect Effects 0.000 abstract description 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 208000012153 swine disease Diseases 0.000 abstract 1
- 239000012646 vaccine adjuvant Substances 0.000 abstract 1
- 229940124931 vaccine adjuvant Drugs 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 description 14
- 238000002649 immunization Methods 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 10
- 238000001976 enzyme digestion Methods 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 102000004889 Interleukin-6 Human genes 0.000 description 8
- 108090001005 Interleukin-6 Proteins 0.000 description 8
- 229940100601 interleukin-6 Drugs 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 102000003777 Interleukin-1 beta Human genes 0.000 description 5
- 108090000193 Interleukin-1 beta Proteins 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 231100000517 death Toxicity 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 239000008118 PEG 6000 Substances 0.000 description 4
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000011067 equilibration Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 108010002352 Interleukin-1 Proteins 0.000 description 3
- 102000000589 Interleukin-1 Human genes 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 230000002163 immunogen Effects 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000000770 proinflammatory effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- 241000711484 Transmissible gastroenteritis virus Species 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000002301 combined effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- -1 isopropyl- Chemical group 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000000464 low-speed centrifugation Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 102100031673 Corneodesmosin Human genes 0.000 description 1
- 101710139375 Corneodesmosin Proteins 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 206010050685 Cytokine storm Diseases 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102100026720 Interferon beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 102000003814 Interleukin-10 Human genes 0.000 description 1
- 108090000174 Interleukin-10 Proteins 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 101150073872 ORF3 gene Proteins 0.000 description 1
- 229940096437 Protein S Drugs 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 101150010882 S gene Proteins 0.000 description 1
- 101710198474 Spike protein Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 101150087698 alpha gene Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000011091 antibody purification Methods 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229940031567 attenuated vaccine Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 206010052015 cytokine release syndrome Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000000688 enterotoxigenic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000007499 fusion processing Methods 0.000 description 1
- 230000006303 immediate early viral mRNA transcription Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940031551 inactivated vaccine Drugs 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000011140 intestinal infectious disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 101150040063 orf gene Proteins 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000013190 sterility testing Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110668820.8A CN113121681B (zh) | 2021-06-17 | 2021-06-17 | 一种抗炎抗猪流行性腹泻病毒卵黄抗体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110668820.8A CN113121681B (zh) | 2021-06-17 | 2021-06-17 | 一种抗炎抗猪流行性腹泻病毒卵黄抗体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113121681A CN113121681A (zh) | 2021-07-16 |
CN113121681B true CN113121681B (zh) | 2021-09-10 |
Family
ID=76782984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110668820.8A Active CN113121681B (zh) | 2021-06-17 | 2021-06-17 | 一种抗炎抗猪流行性腹泻病毒卵黄抗体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113121681B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113796542B (zh) * | 2021-10-21 | 2023-06-13 | 江南大学 | 海参卵黄蛋白在制备缓解结肠炎的功能性食品中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109517044A (zh) * | 2018-12-28 | 2019-03-26 | 衡阳师范学院 | 一种猪流行性腹泻病毒基因工程抗原和抗体 |
CN112029792A (zh) * | 2020-07-10 | 2020-12-04 | 山东百瑞凯来生物科技有限公司 | 一种具有抗炎作用的鸭病毒性肝炎卵黄抗体及其制备方法和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001048018A1 (en) * | 1999-12-27 | 2001-07-05 | University Of Manitoba | Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens |
-
2021
- 2021-06-17 CN CN202110668820.8A patent/CN113121681B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109517044A (zh) * | 2018-12-28 | 2019-03-26 | 衡阳师范学院 | 一种猪流行性腹泻病毒基因工程抗原和抗体 |
CN112029792A (zh) * | 2020-07-10 | 2020-12-04 | 山东百瑞凯来生物科技有限公司 | 一种具有抗炎作用的鸭病毒性肝炎卵黄抗体及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
猪流行性腹泻病毒及其卵黄抗体研究进展;梅小强等;《畜牧与兽医》;20191231;第51卷(第7期);127-131 * |
Also Published As
Publication number | Publication date |
---|---|
CN113121681A (zh) | 2021-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010502199A (ja) | リコンビナントヘリコバクターピロリの経口ワクチン及びその調製方法 | |
CN113461788B (zh) | 猫冠状病毒重组抗原、其基因工程亚单位疫苗及应用 | |
CN112921005B (zh) | 一株杂交瘤细胞株及其产生的犬细小病毒vp2蛋白单克隆抗体和应用 | |
WO2018000708A1 (zh) | 一种番鸭细小病毒亚单位疫苗 | |
CN113845576A (zh) | 重组猫疱疹病毒1型gB-gD蛋白及其应用 | |
KR101600959B1 (ko) | 가금 레오바이러스 시그마 c 단백질의 항원 결정기를 포함하는 재조합 단백질 및 이에 대한 항체 | |
CN113121681B (zh) | 一种抗炎抗猪流行性腹泻病毒卵黄抗体及其应用 | |
JP2023544396A (ja) | ロタウイルスに対するワクチン接種のために有用な融合タンパク質 | |
JPH0657663B2 (ja) | 多機能特異的抗体の製造方法 | |
CN109467606A (zh) | 一种大肠杆菌肠毒素STa-LTB-STb融合蛋白及其编码基因和应用 | |
CN111850002A (zh) | 牛支原体分泌蛋白MbovP570的应用 | |
CN113230394B (zh) | 一种用于牛病毒性腹泻的rna疫苗及其构建方法 | |
JP6877788B2 (ja) | ブタのFc断片と融合した抗原およびこれを含むワクチン組成物 | |
CN113855795B (zh) | 禽戊型肝炎病毒orf2亚单位疫苗 | |
CN113940993B (zh) | 一种鲈鱼弹状病毒g2-2m亚单位疫苗及其制备方法 | |
KR20080029176A (ko) | 인간로타바이러스 및 이를 이용한 백신 조성물 | |
CN106397602B (zh) | 一种分子佐剂加强型鸡马立克氏病蛋白工程疫苗 | |
CN109517044B (zh) | 一种猪流行性腹泻病毒基因工程抗原和抗体 | |
CN104558145B (zh) | 一种胎球蛋白a重组蛋白及多克隆抗体的制备方法 | |
CN109593136B (zh) | 禽副粘病毒融合蛋白及其制备方法、应用和用于鸽子的apmv疫苗 | |
CN111560386A (zh) | 一种可溶性猪圆环病毒2型Cap蛋白及应用 | |
CN111793137A (zh) | 一种Hp四价抗原及其制备方法与应用 | |
CN112592410B (zh) | 犬腺病毒基因工程亚单位疫苗、其制备方法及应用 | |
CN115819625B (zh) | 一种大肠杆菌四价抗原融合多肽 | |
CN113943355B (zh) | 一种鲈鱼弹状病毒g2-2m重组蛋白及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211230 Address after: 261061 in the biomedical science and Technology Industrial Park to the east of Gaoxin 2nd Road, south of Jiankang East Street, Gaoxin District, Weifang City, Shandong Province Patentee after: SHANDONG BEST CARE BIOTECHNOLOGY Co.,Ltd. Patentee after: Shandong Bairui Kailai Biotechnology Co.,Ltd. Address before: 261061 in the biomedical science and Technology Industrial Park to the east of Gaoxin 2nd Road, south of Jiankang East Street, Gaoxin District, Weifang City, Shandong Province Patentee before: SHANDONG BEST CARE BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220708 Address after: 261061 Biotechnology Industrial Park, east of Gaoxin Second Road, south of Jiankang East Street, high tech Zone, Weifang City, Shandong Province Patentee after: SHANDONG BEST CARE BIOTECHNOLOGY Co.,Ltd. Address before: 261061 in the biomedical science and Technology Industrial Park to the east of Gaoxin 2nd Road, south of Jiankang East Street, Gaoxin District, Weifang City, Shandong Province Patentee before: SHANDONG BEST CARE BIOTECHNOLOGY Co.,Ltd. Patentee before: Shandong Bairui Kailai Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: An anti-inflammatory and anti porcine epidemic diarrhea virus egg yolk antibody and its application Effective date of registration: 20230426 Granted publication date: 20210910 Pledgee: Bank of Communications Ltd. Weifang branch Pledgor: SHANDONG BEST CARE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023980039273 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20210910 Pledgee: Bank of Communications Ltd. Weifang branch Pledgor: SHANDONG BEST CARE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023980039273 |